Tech Company Financing Transactions

Aratana Therapeutics Funding Round

Aratana Therapeutics closed a $20 million Series A funding round on 1/7/2011. Backers included Avalon Ventures, MPM Capital and private investors.

Transaction Overview

Announced On
1/7/2011
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors

Avalon Ventures (Lead Investor) (Jay Lichter)

MPM Capital (Lead Investor) (Steven St. Peter)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1901 Olathe Blvd.
Kansas City, KS 66103
USA
Email Address
Not Recorded
Overview
Aratana Therapeutics develops innovative therapies for the animal health industry.
Profile
Aratana Therapeutics LinkedIn Company Profile
Social Media
Aratana Therapeutics Company Twitter Account
Company News
Aratana Therapeutics News
Facebook
Aratana Therapeutics on Facebook
YouTube
Aratana Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Steven Peter
  Steven Peter LinkedIn Profile  Steven Peter Twitter Account  Steven Peter News  Steven Peter on Facebook
Chief Scientific Officer
Linda Rhodes
  Linda Rhodes LinkedIn Profile  Linda Rhodes Twitter Account  Linda Rhodes News  Linda Rhodes on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/7/2011: Personal venture capital transaction
Next: 1/7/2011: 23andMe venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary